Ringholm, Lene
Søholm, Julie Carstens
Pedersen, Berit Woetmann
Clausen, Tine Dalsgaard
Damm, Peter
Mathiesen, Elisabeth Reinhardt
Article History
Accepted: 10 November 2024
First Online: 22 November 2024
Declarations
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: LR has received a grant (grant number: U1111-1209-6358) from Novo Nordisk A/S for the CopenFast trial, an investigator sponsored study. The salary of JCS is fully covered by the Grant number: U1111-1209-6358 from Novo Nordisk A/S. BWP and TDC declare no conflicts of interest. PD has participated in clinical studies on the use of insulin in pregnant women with preexisting diabetes in collaboration with Novo Nordisk, but no personal honorarium was involved. ERM has contracts with Novo Nordisk for the investigation of the Expect trial and the Evolve trial that are investigating newer insulin analogs and insulin pump treatment in pregnant women with diabetes, has received honoraria from Novo Nordisk for lectures, received support from Novo Nordisk for traveling to one international scientific meeting in the field of diabetes, and is participating an Advisory board for Novo Nordisk.